Entry Detail



General Information

Database ID:exR0750335
RNA Name:hsa-miR-6747-3p
RNA Type:miRNA
Chromosome:chr11
Starnd:-
Coordinate:
Start Site(bp):62567011End Site(bp):62567031
External Links:hsa-miR-6747-3p



Disease Information

Disease Name:Lactation
Disease Category:Other Diseases
MeSH ID:D007774
Type:Phenomena and Processes Category/Reproductive and Urinary Physiological Phenomena
Alias:Milk Secretion//Milk Secretions//Lactation, Prolonged//Lactations, Prolonged//Prolonged Lactation//Prolonged Lactations



Expression Detail

GEO ID:GSE75726
Description:Human milk cells and lipids conserve numerous known and novel miRNAs, some of which are differentially expressed during lactation
Experimental Design:Time Series
Case Disease Type:Lactation
Case Disease SubType:NA
Case Sample:Post-feeding, month 6 of lactation
Control Sample:Post-feeding, month 2 of lactation
Number of Case:5
Number of Control:5
Number of Samples:10





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
IRF2BPL
chr14
77024543
77028708
-
ACTR6
chr12
100199122
100241865
+
AP002990.1
chr11
62559603
62591531
-
B3GNT4
chr12
122203681
122208952
+
DPY30
chr2
31867809
32039805
-
EEF1G
chr11
62559596
62574086
-
METAP1
chr4
98995659
99062809
+
MTRNR2L12
chr3
96617188
96618236
-
MYO18A
chr17
29071124
29180412
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:27074017
Title:Human Milk Cells and Lipids Conserve Numerous Known and Novel miRNAs, Some of Which Are Differentially Expressed during Lactation
Author:Alsaweed M, Lai CT, Hartmann PE, Geddes DT, Kakulas F
Journal:PLoS One. 2016 Apr 13;11(4):e0152610.
Description:We used deep sequencing to profile miRNAs in the cell and lipid fractions of HM obtained post-feeding from 10 lactating women in months 2, 4, and 6 postpartum.